{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T07:11:53Z","timestamp":1778483513587,"version":"3.51.4"},"reference-count":0,"publisher":"Hogrefe Publishing Group","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapeutische Umschau"],"published-print":{"date-parts":[[2012,5,1]]},"abstract":"<jats:p> Die renovaskul\u00e4re Hypertonie ist bedingt durch eine Minderperfusion der Niere(n). Die Diagnose kann schwierig sein. Es ist nicht immer leicht zu unterscheiden, ob eine Nierenarterienstenose signifikant ist, oder ob eine Krankheit der kleinen Nierengef\u00e4\u00dfe vorliegt. Bei der Nierenarterienstenose erh\u00f6ht sich das Renin im Plasma. Deshalb ist die Blockade des Renin-Angiotensin-Aldosteron-Systems wichtig in dieser Situation. Bei bilateralen Nierenarterienstenosen steht eine Volumen\u00fcberlastung im Vordergrund. Deshalb geh\u00f6ren in dieser Situation Diuretika zur Therapie. Die Indikation zur endovaskul\u00e4ren oder chirurgischen Therapie ist heute kontrovers, gesichert bei Flash-Lungen\u00f6dem und bei fibromuskul\u00e4rer Dysplasie. Alle Patienten mit renovaskul\u00e4rer Hypertonie ben\u00f6tigen eine Behandlung der kardiovaskul\u00e4ren Risikofaktoren. <\/jats:p>","DOI":"10.1024\/0040-5930\/a000286","type":"journal-article","created":{"date-parts":[[2013,2,2]],"date-time":"2013-02-02T02:17:26Z","timestamp":1359771446000},"page":"279-281","source":"Crossref","is-referenced-by-count":2,"title":["Hypertoniebehandlung bei Nierenarterienstenose"],"prefix":"10.1024","volume":"69","author":[{"family":"Vogt","sequence":"first","affiliation":[{"name":"Service de N\u00e9phrologie et d'Hypertension, D\u00e9partement de M\u00e9decine, Centre Hospitalier Universitaire Vaudois CHUV, Universit\u00e9 de Lausanne"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Maillard","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie et d'Hypertension, D\u00e9partement de M\u00e9decine, Centre Hospitalier Universitaire Vaudois CHUV, Universit\u00e9 de Lausanne"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Burnier","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie et d'Hypertension, D\u00e9partement de M\u00e9decine, Centre Hospitalier Universitaire Vaudois CHUV, Universit\u00e9 de Lausanne"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"101","container-title":["Therapeutische Umschau"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/econtent.hogrefe.com\/doi\/pdf\/10.1024\/0040-5930\/a000286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T10:52:36Z","timestamp":1652007156000},"score":1,"resource":{"primary":{"URL":"https:\/\/econtent.hogrefe.com\/doi\/10.1024\/0040-5930\/a000286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,1]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5,1]]}},"alternative-id":["10.1024\/0040-5930\/a000286"],"URL":"https:\/\/doi.org\/10.1024\/0040-5930\/a000286","relation":{},"ISSN":["0040-5930","1664-2864"],"issn-type":[{"value":"0040-5930","type":"print"},{"value":"1664-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,1]]}}}